REGENXBIO Inc. (RGNX) › Total LiabilitiesREGENXBIO Inc. (RGNX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2014: $9.19M2015: $4.57M2016: $10.99M2017: $15.65M2018: $34.97M2019: $47.71M2020: $330.41M2021: $349.61M2022: $317.07M2023: $262.23M2024: $206.34M2025: $350.30M$350.30M2014Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$350.30M+69.8%2024$206.34M-21.3%2023$262.23M-17.3%2022$317.07M-9.3%2021$349.61M+5.8%2020$330.41M+592.5%2019$47.71M+36.4%2018$34.97M+123.5%2017$15.65M+42.3%2016$10.99M+140.5%2015$4.57M-50.2%2014$9.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share